[go: up one dir, main page]

BRPI0814366A2 - Complexos de grp94 com imunoglobulina g humana - Google Patents

Complexos de grp94 com imunoglobulina g humana

Info

Publication number
BRPI0814366A2
BRPI0814366A2 BRPI0814366-8A2A BRPI0814366A BRPI0814366A2 BR PI0814366 A2 BRPI0814366 A2 BR PI0814366A2 BR PI0814366 A BRPI0814366 A BR PI0814366A BR PI0814366 A2 BRPI0814366 A2 BR PI0814366A2
Authority
BR
Brazil
Prior art keywords
grp94
immunoglobulin
complexes
human
grp94 complexes
Prior art date
Application number
BRPI0814366-8A2A
Other languages
English (en)
Inventor
Paola Finotti
Original Assignee
Paolo Primiero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paolo Primiero filed Critical Paolo Primiero
Publication of BRPI0814366A2 publication Critical patent/BRPI0814366A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BRPI0814366-8A2A 2007-07-24 2008-06-30 Complexos de grp94 com imunoglobulina g humana BRPI0814366A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000252A ITPD20070252A1 (it) 2007-07-24 2007-07-24 Complessi di grp94 ed immunoglobuline g umane
PCT/EP2008/058375 WO2009013097A1 (en) 2007-07-24 2008-06-30 Complexes of grp94 with human immunoglobulin g

Publications (1)

Publication Number Publication Date
BRPI0814366A2 true BRPI0814366A2 (pt) 2015-01-27

Family

ID=39847112

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814366-8A2A BRPI0814366A2 (pt) 2007-07-24 2008-06-30 Complexos de grp94 com imunoglobulina g humana

Country Status (8)

Country Link
US (1) US20100316642A1 (pt)
EP (1) EP2185579A1 (pt)
CN (1) CN101754976A (pt)
BR (1) BRPI0814366A2 (pt)
CA (1) CA2694001A1 (pt)
EA (1) EA201000236A1 (pt)
IT (1) ITPD20070252A1 (pt)
WO (1) WO2009013097A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201705844SA (en) * 2015-02-06 2017-08-30 Heat Biologics Inc Vector co-expressing vaccine and costimulatory molecules
US20180136222A1 (en) * 2015-05-20 2018-05-17 Paola Finotti Method for detecting and measuring endogenous complexes as a new tumour marker
CN108727464A (zh) * 2018-06-06 2018-11-02 重庆医科大学附属儿童医院 一种新的蛋白提取试剂及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55162059A (en) * 1979-06-05 1980-12-17 Mochida Pharmaceut Co Ltd Measuring method for antigen, antibody or their complex and measurement reagent kit
DE69942810D1 (de) * 1998-02-20 2010-11-11 Univ Miami Modifizierter Hitzeschockprotein-Antigenpeptid-Komplex
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
DE10033245A1 (de) * 2000-07-10 2002-01-24 Singh Jasuja Harpreet Verwendungen des Hitzeschockproteins gp96

Also Published As

Publication number Publication date
WO2009013097A1 (en) 2009-01-29
CN101754976A (zh) 2010-06-23
EP2185579A1 (en) 2010-05-19
ITPD20070252A1 (it) 2009-01-25
US20100316642A1 (en) 2010-12-16
CA2694001A1 (en) 2009-01-29
EA201000236A1 (ru) 2010-08-30

Similar Documents

Publication Publication Date Title
SMT201500186B (it) Autoanticorpi umani anti-alfa-sinucleina
HRP20160875T1 (hr) Humana anti-b7rp1 neutralizirajuća antitijela
DK2274012T3 (da) Cytotoksisk immunoglobulin
BRPI0920573A2 (pt) complexos tcr imunoterapêuticos
CR10161A (es) Inmunoglobulinas
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0915419A2 (pt) imunoglobulinas com agregação reduzida
BRPI0820819A2 (pt) Formulação de anticorpos
EP2261083A4 (en) DOOR MIRROR DEVICE
NO20072812L (no) Forbedret oreenhet
DK2066695T3 (da) Anti-myostatin-antistoffer
EP2207803A4 (en) Cd9-specific human antibodies
FI20075278A0 (fi) Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
BRPI0811607A2 (pt) Modelagem de diagnóstico remoto
DE602007013377D1 (de) Fahrzeugtür
BRPI0821773A2 (pt) Monossebacato derivado de pirazol
DE602008003253D1 (de) Schiebeelement
BRPI0810559A2 (pt) Macadores de doenças
HRP20150195T1 (xx) Antibakterijski peptidi
CY2022026I1 (el) Συμπλοκα πρωτεϊνων-πολυμερων
EP2372982A4 (en) GLEITSCHARNIERMECHANISMUS
BRPI0818631A2 (pt) Cobertura de carril
BRPI0814366A2 (pt) Complexos de grp94 com imunoglobulina g humana
FR2912066B1 (fr) Engin de glisse
EP2114655A4 (en) PLATE FOR MOLDING SYSTEM HAVING ANTI-TILT STRUCTURE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.